Retraction notices

Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials

Type
Retraction
Notice date
4/12/2018 0:00
Journal
Journal of the American Academy of Dermatology
Publisher
Elsevier
Notice DOI
10.1016/j.jaad.2018.04.011
Original paper DOI
10.1016/j.jaad.2018.01.028

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.